Are you Dr. Steinberg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 37 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
830 Harrison Ave
Moakley, 3rd Floor
Boston, MA 02118Phone+1 617-638-6428Fax+1 617-638-5756- Is this information wrong?
Summary
- Dr. Martin Steinberg, MD is a hematologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is a Professor at Boston University School of Medicine.
Education & Training
- Tufts Medical CenterResidency, Internal Medicine, 1966 - 1968
- NYU Grossman School of MedicineInternship, Transitional Year, 1962 - 1963
- Tufts University School of MedicineClass of 1962
Certifications & Licensure
- MA State Medical License 1965 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1979
Publications & Presentations
PubMed
- "Severity" in adult sickle cell disease.Martin H Steinberg, Gladwin, M. T., Gladwin, M. T., Gladwin, M. T., Mark T Gladwin> ;American Journal of Hematology. 2023 Oct 1
- 2 citationsAn integrated therapeutic approach to sickle cell disease management beyond infancy.Jean-Antoine Ribeil, Galia Pollock, Haydar Frangoul, Martin H Steinberg> ;American Journal of Hematology. 2023 Jul 1
- 1 citationsFetal hemoglobin per erythrocyte (HbF/F-cell) after gene therapy for sickle cell anemia.Paola Sebastiani, Martin H Steinberg> ;American Journal of Hematology. 2023 Feb 1
- Join now to see all
Press Mentions
- What if a CRISPR Cure Isn’t Such an Easy Choice?November 9th, 2023
- FDA Weighs Gene-Editing Treatments’ Curative Possibilities Against Potential RisksDecember 12th, 2023
- FDA Approves Two Gene Therapies for Sickle Cell, Including First CRISPR-Based MedicineDecember 12th, 2023
Grant Support
- Globin Gene Expression In Sickle Cell Genotype-Specific IPS CellsNational Heart, Lung, And Blood Institute2011
- Sickle Cell ScholarNational Heart, Lung, And Blood Institute2008–2011
- Administrative CoreNational Heart, Lung, And Blood Institute2008–2011
- Boston Comprehensive Sickle Cell CenterNational Heart, Lung, And Blood Institute2003–2011
- Genetic Diversity Of Sickle Cell AnemiaNational Heart, Lung, And Blood Institute2009–2010
- Genome-Wide Association Studies In Sickle Cell Anemia And In CentenariansNational Heart, Lung, And Blood Institute2007–2010
- Genetic Modulation Of Sickle Cell DiseaseNational Heart, Lung, And Blood Institute2006–2010
- Genetic Modulation Of Sickle Cell AnemiaFogarty International Center2006–2008
- Pulse Arginine Butyrate In Sickle Cell DiseaseNational Center For Research Resources2007
- Research Scholar ProgramNational Heart, Lung, And Blood Institute2004–2007
- Core--Inter Center Collaborative Clinical ResearchNational Heart, Lung, And Blood Institute2004–2007
- Core--Clinical CoreNational Heart, Lung, And Blood Institute2004–2007
- Determinants Of Hbf Response To HydroxyureaNational Heart, Lung, And Blood Institute2002–2005
- Genetic Modulation Of Sickle Cell AnemiaNational Heart, Lung, And Blood Institute2001–2005
- Comprehensive Sickle Cell CenterNational Heart, Lung, And Blood Institute2001–2002